Combination Drug Delivery Approach as an Effective Therapy for Various Diseases
-10%
portes grátis
Combination Drug Delivery Approach as an Effective Therapy for Various Diseases
Kesharwani, Prashant
Elsevier Science & Technology
04/2022
436
Mole
Inglês
9780323858731
15 a 20 dias
910
Descrição não disponível.
Section 1: Combination drug delivery approaches against various diseases 1. Drug resistance as challenges to effective therapy 2. Overcoming the challenges of drug resistance through combination drug delivery approach 3. Combination drug delivery approaches for pulmonary diseases 4. Combination drug delivery approaches in ophthalmology 5. Combination drug delivery system to enhance the transdermal drug delivery 6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis 7. Combination drug delivery approaches for cardiovascular disease 8. Combination drug delivery approaches for viral infection 9. Combination drug delivery approaches for malaria parasite 10. Combination drug delivery approaches for tuberculosis
Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment
Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and postmarket regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems
Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment
Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and postmarket regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Anticancer drug; Antimalarial drugs; Antituberculosis drugs; Aptamers; Cancer; Cancer resistance; Cancer therapy; Cardiovascular diseases; Combination drugs; Combination of drug; Combination of therapy; Combination therapy; Combinational therapy; Combined therapy; Drug delivery; Drug delivery routes; Drug delivery systems; Drug resistance; Drug resistance approach; Drug safety; Drug treatment; Drug-device combinations; Dual-based mechanism; Enzyme prodrug therapy; Exosomes; Extracellular vesicles; Gene therapy; Green chemistry; Green solvents; Inorganic nanoparticles; Liposomes; Low-temperature transition mixtures; Malaria; MiRNA; Nanocarriers; Nanomedicine; Nanoparticle; Nanoparticles; Nanotechnology; Ocular diseases; Ocular drug delivery; Organic nanoparticles; Patient compliance; Plasmodium falciparum; Postmarketing regulation; Premarketing regulation; Prodrugs; RBCs; Rheumatoid arthritis; Safety regulation; Sequential combinational therapy; SiRNA; Skin permeation; Stratum corneum; Synergistic effects; Therapeutic activity; Transdermal route; Tuberculosis infection; Tumor cells
Section 1: Combination drug delivery approaches against various diseases 1. Drug resistance as challenges to effective therapy 2. Overcoming the challenges of drug resistance through combination drug delivery approach 3. Combination drug delivery approaches for pulmonary diseases 4. Combination drug delivery approaches in ophthalmology 5. Combination drug delivery system to enhance the transdermal drug delivery 6. Combination drug delivery approaches in arthritis rheumatoid and osteoarthritis 7. Combination drug delivery approaches for cardiovascular disease 8. Combination drug delivery approaches for viral infection 9. Combination drug delivery approaches for malaria parasite 10. Combination drug delivery approaches for tuberculosis
Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment
Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and postmarket regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems
Section 2: Combination drug delivery approaches against cancer 11. Combination drug delivery approaches for cancer therapy 12. Prodrug-based drug delivery approaches in cancer combination therapy 13. Combination of anticancer drugs with microRNA therapeutics as cancer therapeutics 14. Cocktail chemotherapy by combination drug delivery systems 15. Nanotechnology-mediated combinational drug delivery approach for cancer therapy 16. Combinational chemotherapy and hyperthermia in cancer treatment
Section 3: Combination drug delivery approaches challenges and future perspectives 17. Premarket review and postmarket regulation of combination drug products 18. Challenges associated with nanoparticulate combination drug delivery systems 19. Concluding remarks and future perspective of combination drug delivery systems
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Anticancer drug; Antimalarial drugs; Antituberculosis drugs; Aptamers; Cancer; Cancer resistance; Cancer therapy; Cardiovascular diseases; Combination drugs; Combination of drug; Combination of therapy; Combination therapy; Combinational therapy; Combined therapy; Drug delivery; Drug delivery routes; Drug delivery systems; Drug resistance; Drug resistance approach; Drug safety; Drug treatment; Drug-device combinations; Dual-based mechanism; Enzyme prodrug therapy; Exosomes; Extracellular vesicles; Gene therapy; Green chemistry; Green solvents; Inorganic nanoparticles; Liposomes; Low-temperature transition mixtures; Malaria; MiRNA; Nanocarriers; Nanomedicine; Nanoparticle; Nanoparticles; Nanotechnology; Ocular diseases; Ocular drug delivery; Organic nanoparticles; Patient compliance; Plasmodium falciparum; Postmarketing regulation; Premarketing regulation; Prodrugs; RBCs; Rheumatoid arthritis; Safety regulation; Sequential combinational therapy; SiRNA; Skin permeation; Stratum corneum; Synergistic effects; Therapeutic activity; Transdermal route; Tuberculosis infection; Tumor cells
